Asthma Spacers Market

Asthma Spacers Market Outlook

Global asthma spacer sales will grow at a moderate rate between 2021 and 2031. The market is poised to surpass US$ 1803.9 Mn by 2031 end, registering a CAGR of around 3.9% during the forecast period.

Owing to its efficient delivery of medicine in slow and controlled manner, aerochamber is set to register more than two-fifth of the asthma spacers market, reaching a valuation of around US$ 729.9 Mn by 2031.

North America leads the asthma spacers market. The market is expected to surpass US$ 739.6 Mn with a market share of around 41% during the forecast period. This can be attributed to the increasing prevalence of asthma attacks in the region.

2016-2021 Asthma Spacers Market Demand Outlook in Comparison to 2021-2031 Forecast

The swift growth of asthma spacers market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, expanding healthcare sector and increasing level of air pollution.

According to WHO, asthma affected nearly 262 million people and caused around 461000 deaths in 2019. Asthma is perhaps one of the most common chronic disease among children and old age people.

Asthma is a chronic condition, which means that there is no permanent cure for it. However, people are using various treatments and lifestyle measures to manage the condition and lead a normal life. Inhalers are being increasingly utilized to counter the symptoms of asthma.

As inhalers require patients to time a good, deep breath exactly while the medicine is released, majority of them are unable to use these devices effectively. To improve the intake of medication, spacers are being employed. This results in the growing demand for asthma spacers across the globe.

A spacer gives patients more time to use the inhaler which makes the process simpler. It reduces the need for coordination when pressing the inhales and breathing in the medicine. Moreover, spacers extend the amount of time the inhales take to deliver medicine and reduce the risk of side effects such as oral thrush. As a result, more and more patients are opting for it.

Growing preference for asthma spacers for better delivery of aerosolized medication is expected to drive the market swiftly during the forecast period. In addition, various initiatives taken by government and healthcare organizations to spread awareness about respiratory diseases along with their preventive and curative measures is positively impacting the demand for spacers.

Increasing pollution level is another factor that leads to emergence of various respiratory diseases. It has been observed that various harmful pollutants such as Sulphur dioxide. Ozone, nitrogen oxide trigger asthma attacks in susceptible individuals.

North America is leading the asthma spacers market as a result of increased asthma patient pool along with highly sophisticated healthcare infrastructure. According to Centers for Diseases Control and Prevention (CDC), around 25 million Americans are suffering from asthma. This is greatly affecting the sales of asthma spacers.

Key Companies operating in the asthma spacers market are focusing on organic and inorganic growth strategies such as product launches and product approvals. They have adopted various strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

For instance, in July 2021 Philip Morris International Inc. (PMI) agreed to buy asthma drug maker Vectura Group Plc for $ 1.2 billion. The acquisition will accelerate PMIs beyond nicotine strategy and expands its product pipeline development capabilities in inhaled therapeutics.

In 2018 Medical Developments International Ltd, the Australian manufacturer of healthcare products launched new anti-static version of the Space Chamber Plus. The new model spacer is designed to deliver medication more effectively to the lungs.

Similarly, Rossmax International Ltd launched various asthma spacer products such as AS175 Aero Spacer- Valved Holding Chamber with portable design and easy holding features.

Increased Incidence of Asthma to Augment Demand for Asthma Spacers

Asthma spacers market is expected to grow moderately, at a CAGR of 3.9% between 2021 and 2031. The global geriatric population is proliferating at a rapid pace. By 2050, the number of elderly people is expected to surpass 2 billion, accounting for 22% of the total global population.

This rising prevalence of asthma among the elderly is leading to an increase in the demand for asthma spacers. Environmental degradation, leading to poor and reduced air quality

Moreover, studies have demonstrated that 7 out of 10 patients are unable to use inhaler devices effectively. Inhalers require patients to time a good, deep breath exactly while the medicine is released.

Most people experience trouble adjusting this. To improve the intake of medication, demand for spacers is expected to be augmented in the foreseeable future.

 Aerochambers Reign the market followed by Micro Spacers & Flexi-Chambers

Aerochambers are expected to gain widespread usage throughout the forecast period.

This is attributed to delivery of the medicine in a slow, controlled manner. Moreover, they prevent wastage by ensuring minimum leakage of medicine into the air.

The aerochamber segment is anticipated to register more than two-fifth of the asthma spacers market, surpassing a value of US$ 792.94 Mn by 2031.

Moreover, demand for devices such as micro spacers and flexi-chambers will witness an uptick, poised to grow at a CAGR of 3.9% between 2021 and 2031.

North America to Retain Market Attractiveness, Asia-Pacific Catching Up

North America shall retain its market attractiveness throughout the forecast period. This is in view of rising incidence of asthma attacks among patients in this region, which has led to an increase in healthcare expenditure.

By 2031, North America is anticipated to register a market share of 41%, surpassing a figure of US$ 739.61 Mn.

Aerochambers are expected to contribute more than half the share in the North American asthma spacers market.

Trailing behind North America is Asia-Pacific, expected to expand at a CAGR of 4.5%.

Development of healthcare sector, in the wake of burgeoning population and subsequent increase in health expenditure, is expected to leverage the asthma spacers market in Asia-Pacific.

In addition, increased preference for asthma spacers for better delivery of aerosolized medication is expected to steer the asthma spacers market on an upward trajectory during the forecast period.

Competitive Landscape

The asthma spacers market is highly fragmented, with a number of players having a footprint in the market.

These include

• Trudell Medical International
• Koninklijke Philips N.V
• GlaxoSmithKline
• Medical Developments International
• Visiomed Group Ltd.
• Cipla Ltd.
• Clement Clarke
• AstraZeneca Merck & Co.
• Lupin Pharmaceuticals Inc.

Acquisition of product profile of emerging players is a major strategy by key market players.

These acquisitions are mostly in the research and development domain where they aim to co-develop innovative technologies.

For instance, Trudell International is committed to continuous innovation to fulfil unmet clinical needs of asthma patients.

Its AEROCHAMBER PLUS FLOW-VU ensures that medicine is delivered where it is required. It consists of a dedicated inhalation indicator which helps co-ordinate actuation with inhalation.

Similarly, Medical Developments International has developed the Anti-Static Compact Space Chamber Plus, which ensures efficient delivery of medicine to the lungs.

It is equipped with the Cross Valve Technology, designed to provide low resistance, one-way flow during inhalation for improved drug delivery and ease of use.

Asthma spacers market Segmentation

Fact.MR has studied the asthma spacers market with detailed segmentation on the basis product type, application and key regions.

• By Product Type :

  • Aerochambers
  • Optichambers
  • Volumatic
  • Inspirease
  • Others

• By Distribution Channel :

  • Retail Pharmacy
  • e-Commerce
  • Hospital Pharmacy

• By Key Regions :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”